HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gene for topoisomerase III maps within the Smith-Magenis syndrome critical region: analysis of cell-cycle distribution and radiation sensitivity.

Abstract
Smith-Magenis syndrome (SMS) is caused by an interstitial deletion of chromosome band 17p11.2 averaging 4-5 Mb. This deletion is likely to contain a large number of genes, each of which could potentially contribute toward the clinical phenotype. We report that the gene for topoisomerase III (hTOP3) is commonly deleted in SMS patients and maps between D17S447 and D17S258 on the short arm of chromosome 17. Cellular studies of SMS patient lymphoblasts and their respective parental cell lines were undertaken to determine the consequences of haploinsufficiency of hTOP3. Our studies indicate that hemizygosity for hTOP3 does not appreciably affect cell-cycle kinetics or activation of ionizing radiation-sensitive cell-cycle checkpoints. Furthermore, the induction of apoptosis in response to ionizing radiation in SMS and parental cells was similar. Our studies suggest that haploinsufficiency of hTOP3 does not have a major impact on the behavior of cells from SMS patients and may not play a significant role in the SMS phenotype.
AuthorsS H Elsea, E Fritz, R Schoener-Scott, M S Meyn, P I Patel
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 75 Issue 1 Pg. 104-8 (Jan 06 1998) ISSN: 0148-7299 [Print] United States
PMID9450867 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA Topoisomerases, Type I
Topics
  • Abnormalities, Multiple (enzymology, genetics)
  • Cell Cycle (genetics, radiation effects)
  • Cells, Cultured
  • Chromosome Deletion
  • Chromosomes, Human, Pair 17 (ultrastructure)
  • DNA Topoisomerases, Type I (genetics)
  • Haplotypes
  • Humans
  • Intellectual Disability (enzymology, genetics)
  • Radiation Tolerance (genetics)
  • Restriction Mapping
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: